Assistant Professor of Oncology, Johns Hopkins University School of Medicine
Oncology
Dr. Nilofer S. Azad, MD
|
|
Give Review
Nilofer S. Azad, MD is an expert in the field of Oncology. She researched medicine at Baylor College of Medicine. She received awards:"CMS Meaningful Use Stage 1 Certification". Nilofer S. Azad is a published doctor. She has 35 publications published. The most current publication "Mutational profiling of colorectal cancers with microsatellite instability." She accepts Medicare payments and is registered with Medicare.gov.
Publications
- A robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative Analysis of 5-azacytidine.
- Mutational profiling of coloRectal cancers with microsatellite instability.
- Performance characteristics of next-generation sequencing in clinical mutation detection of coloRectal cancers.
- A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors.
- Analysis of fiducials implanted during EUS for patients with localized rectal cancer receiving high-dose rate endorectal brachytherapy.
- A Phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy in patients with advanced solid Malignancies and per...
- Racial disparities and coloRectal cancer survival in older adults with and without diabetes mellitus.
- A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours.
- Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors.
- A randomized pilot trial of a telephone-based couples intervention for physical intimacy and sexual concerns in coloRectal cancer.
- Detection of circulating tumor DNA in early- and late-stage human Malignancies.
- Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial Cancers.
- Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.
- Gastrointestinal ostomies and sexual outcomes: a comparison of coloRectal cancer patients by ostomy status.
- Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for coloRectal metastases.
- CHFR silencing or microsatellite instability is associated with increased anti-tumor activity of docetaxel or gemcitabine in coloRectal cancer.
- The future of epigenetic therapy in solid tumours-lessons from the past.
- Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced coloRectal cancer.
- DNA-intercalators causing rapid re-expression of methylated and silenced genes in Cancer cells.
- Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
- Reporting of preclinical tumor-graft Cancer therapeutic studies.
- Clinicopathologic Comparison of High-Dose-Rate EndoRectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and I...
- Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatoCellular carcinoma: initial experience in ...
- Hand-foot Skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.
- Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity.
- Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
- Keratoacanthomas associated with sorafenib therapy.
- Proteomics in clinical trials and practice: present uses and future promise.
- Primary anorectal lymphoma presenting as a periAnal abscess in an HIV-positive male.
- Ovarian Cancer in the proteomics era.
- Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity.
- A phase I study of paclitaxel and continuous daily CAI in patients with refractory solid tumors.
- Proteomics as a tool for biomarker discovery.
- The ongoing evolution of proteomics in malignancy.
Schools
Baylor University
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
National Institutes of Health Clinical Center -
Baylor College of Medicine
Hospital
-
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center -
Sibley Memorial Hospital
Drug Facts
| NPI NUMBER | 1568635712 | |
| NPPES Provider LastName | AZAD | |
| NPPES Provider FirstName | NILOFER | |
| NPPES Provider ZIPCode | 200162633 | |
| NPPES Provider State | DC | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 58.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568635712 |
| Last Name Of The Provider | AZAD |
| First Name Of The Provider | NILOFER |
| View All |
Similar Doctors
|
|
Dr. Danijela Jelovac, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mian K. Khalid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yin Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley D. Walker, MD |
|
|
Dr. Davis M. Hahn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen H. Glasser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth M. Jaffee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hyam I. Levitsky, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Samuel R. Denmeade, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Mark J. Levis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dung T. Le, MD |
|
|
Dr. Joshua E. Lubek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Matsui, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. B D. Smith Jr., MD |
|
|
Dr. Michael T. Schweizer, MD
This Doctor is OpenDoctor Recommended.
|